Related Experiment Video
Updated: Jan 4, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
[Inborn errors of high-density lipoprotein metabolism]
1Institut für Klinische Chemie, Universitätsspital Zürich und Universität Zürich, Rämistrasse 100, 8091, Zürich, Schweiz. arnold.voneckardstein@usz.ch.
Insights
Both low and very high levels of high-density lipoprotein cholesterol (HDL-C) increase cardiovascular disease risk. Monogenic diseases affecting HDL-C levels require genetic diagnostics and management of complications.
Area of Science:
- Cardiovascular Medicine
- Human Genetics
- Biochemistry
Background:
- Abnormal high-density lipoprotein cholesterol (HDL-C) levels, both low and very high, are linked to increased atherosclerotic cardiovascular disease (ASCVD) risk and reduced life expectancy.
- Common causes include underlying diseases, lifestyle factors, or medications, necessitating their exclusion.
- Less frequently, monogenic disorders affecting genes like APOA1, ABCA1, LCAT, CETP, LIPC, and SCARB1 result in extreme HDL-C levels.
Purpose of the Study:
- To highlight the significance of genetic and biochemical diagnostics in identifying monogenic causes of dysregulated HDL-C.
- To outline clinical and laboratory indicators suggestive of monogenic HDL disorders.
- To emphasize the importance of managing cardiovascular and renal complications in affected individuals.
Main Methods:
- Review of literature on HDL-C metabolism, genetics, and associated diseases.
- Analysis of clinical presentations and diagnostic approaches for monogenic HDL disorders.
- Discussion of current management strategies for cardiovascular and renal complications.
Main Results:
- Monogenic defects in specific genes (APOA1, ABCA1, LCAT, CETP, LIPC, SCARB1) can lead to very low or very high HDL-C levels.
- Clinical manifestations such as corneal opacities, xanthomas, hepatomegaly, and neuropathy can be indicative of these genetic conditions.
- Genetic sequencing and biochemical analysis are crucial for definitive diagnosis, particularly in cases of absolute HDL deficiency or early-onset ASCVD.
Conclusions:
- Monogenic HDL diseases, while rare, necessitate specific diagnostic considerations.
- Early identification through genetic and biochemical testing is vital for individuals with suggestive clinical or laboratory findings.
- Management focuses on preventing cardiovascular and renal complications through cholesterol and blood pressure control, as no specific treatment exists for the genetic defects themselves.
Abstract:
Both low and very high levels of high-density lipoprotein cholesterol (HDL-C) increase the risk of atherosclerotic cardiovascular disease (ASCVD) and shorten life expectancy. Low and high levels of HDL‑C are often caused by underlying diseases, lifestyle or medication, which should primarily be excluded. Much less frequently, monogenic diseases due to mutations in the APOA1, ABCA1 and LCAT genes are the cause of very low or unmeasurable HDL‑C levels or in the CETP, LIPC and SCARB1 genes for very high HDL‑C values. Genetic and detailed biochemical diagnostics should be considered, especially in cases of absolute HDL deficiency, early onset ASCVD or the presence of clinical symptoms or laboratory values characteristic for deficiencies of apolipoprotein A‑I (ApoA-I), lecithin cholesterol acyltransferase (LCAT) or Tangier disease. These included corneal opacities, xanthomas, large tonsils, hepatomegaly, peripheral neuropathy, proteinuria, anemia or thrombocytopenia. Sequencing of the APOA1 gene should also be considered in familial amyloidosis. There is no specific treatment for monogenic HDL diseases. Cholesterol and blood pressure lowering are indicated for the prevention of cardiovascular and renal complications.
Related Concept Videos
Inborn Errors of Metabolism
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lysosomal Hydrolases

